Eric M. Parker
Secretaría Nacional de Ciencia, Tecnología e Innovación(PA)Universidad Tecnológica de Panamá(PA)
Publications by Year
Research Areas
Receptor Mechanisms and Signaling, Alzheimer's disease research and treatments, Computational Drug Discovery Methods, Cholinesterase and Neurodegenerative Diseases, Neuropeptides and Animal Physiology
Most-Cited Works
- → Chronic Treatment with the γ-Secretase Inhibitor LY-411,575 Inhibits β-Amyloid Peptide Production and Alters Lymphopoiesis and Intestinal Cell Differentiation(2004)715 cited
- → The BACE1 inhibitor verubecestat (MK-8931) reduces CNS β-amyloid in animal models and in Alzheimer’s disease patients(2016)410 cited
- → MLi-2, a Potent, Selective, and Centrally Active Compound for Exploring the Therapeutic Potential and Safety of LRRK2 Kinase Inhibition(2015)329 cited
- → Reconstitutively active G protein-coupled receptors purified from baculovirus-infected insect cells.(1991)283 cited
- → Chimeric muscarinic cholinergic: beta-adrenergic receptors that activate Gs in response to muscarinic agonists.(1990)230 cited
- → Cloning and characterization of the rat GALR1 galanin receptor from Rin14B insulinoma cells(1995)